OBG ManagementWhat is the association of menopausal HT use and risk of Alzheimer disease?April 2, 2019Menopause
Ob.Gyn. NewsFezolinetant looks good for hot flashes in phase 2b trialMarch 26, 2019MenopauseReproductive Endocrinology
Ob.Gyn. NewsBiomarkers predict VTE risk with menopausal oral hormone therapyFebruary 6, 2019Menopause
OBG ManagementIs vaginal estrogen used for GSM associated with a higher risk of CVD or cancer?February 5, 2019MenopauseGynecology
OBG ManagementDoes the type of menopausal HT used increase the risk of venous thromboembolism?February 5, 2019Menopause
Ospemifene, an oral SERM for dyspareunia of menopause: Is it being underutilized?January 30, 2019DyspareuniaMenopause
Ob.Gyn. NewsSoy didn’t up all-cause mortality in breast cancer survivorsJanuary 12, 2019Breast CancerMenopause
OBG ManagementHow does HT in recent and 10+ years past menopause affect atherosclerosis progression?January 8, 2019Menopause
OBG ManagementManaging menopausal vasomotor and genitourinary symptoms after breast cancerJanuary 8, 2019MenopauseGynecologyBreast Cancer
OBG ManagementTo prevent fractures, treating only women with osteoporosis is not enoughDecember 5, 2018MenopauseOsteoporosis
Ob.Gyn. NewsHealthier lifestyle in midlife women reduces subclinical carotid atherosclerosisNovember 28, 2018Preventive CareMenopause
Ob.Gyn. NewsIntimate partner violence and PTSD increase menopausal symptom riskNovember 19, 2018Menopause
